HIV infection among transgender women: Challenges and opportunities

Journal of AIDS and Clinical Research

Volumn 5, Issue 1, 2014, Pages

  Kerr, Thomas ^a,b   Socías, Eugenia ^c   Sued, Omar ^c  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c FUNDACIÓN HUÉSPED   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84897657646     PISSN: None     EISSN: 21556113     Source Type: Journal    
DOI: 10.4172/2155-6113.1000e114     Document Type: Editorial

References (21)

1. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, et al. (2011) Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365: 493-505.
2. Montaner JS, Hogg R, Wood E, Kerr T, Tyndall M, et al. (2006) The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 368: 531-536.
3. Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, et al. (2013) Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebocontrolled phase 3 trial. The Lancet 381: 2083-2090.
4. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, et al. (2010) Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 363: 2587-2599.
5. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, et al. (2012) Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 367: 399-410.
6. Thigpen MC, Rose CE, Paxton LA (2013) Antiretroviral preexposure prophylaxis for HIV prevention. N Engl J Med 368: 82-83.
7. Poteat T, Reisner SL, Radix A (2013) HIV epidemics among transgender women. Curr Opin HIV AIDS.
8. Baral SD, Poteat T, Strömdahl S, Wirtz AL, Guadamuz TE, et al. (2013) Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis 13: 214-222.
9. Silva-Santisteban A, Raymond HF, Salazar X, Villayzan J, Leon S, et al. (2012) Understanding the HIV/AIDS epidemic in transgender women of Lima, Peru: results from a sero-epidemiologic study using respondent driven sampling. AIDS Behav 16: 872-881.
10. Gabrielli E, Ferraioli G, Ferraris L, Riva A, Galli M, et al. (2010) Enfuvirtide administration in HIV-positive transgender patient with soft tissue augmentation: US evaluation. New Microbiol 33: 263-265.
11. Brennan J, Kuhns LM, Johnson AK, Belzer M, Wilson EC, et al. (2012) Syndemic theory and HIV-related risk among young transgender women: the role of multiple, co-occurring health problems and social marginalization. Am J Public Health 102: 1751-1757.
12. Nuttbrock L, Bockting W, Rosenblum A, Hwahng S, Mason M, et al. (2013) Gender abuse, depressive symptoms, and HIV and other sexually transmitted infections among male-to-female transgender persons: a three-year prospective study. Am J Public Health 103: 300-307.
13. Bauer GR, Travers R, Scanlon K, Coleman TA (2012) High heterogeneity of HIV-related sexual risk among transgender people in Ontario, Canada: a province-wide respondent-driven sampling survey. BMC Public Health 12: 292.
14. Das M, Chu PL, Santos GM, Scheer S, Vittinghoff E, et al. (2010) Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One 5: e11068.
15. Machtinger EL, Haberer JE, Wilson TC, Weiss DS (2012) Recent trauma is associated with antiretroviral failure and HIV transmission risk behavior among HIV-positive women and female-identified transgenders. AIDS Behav 16: 2160-2170.
16. Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA (2005) The social structural production of HIV risk among injecting drug users. Soc Sci Med 61: 1026-1044.
17. Rhodes T (2009) Risk environments and drug harms: a social science for harm reduction approach. Int J Drug Policy 20: 193-201.
18. Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, et al. (2010) HIV and risk environment for injecting drug users: the past, present, and future. Lancet 376: 268-284.
19. Blanchard JF, Aral SO (2010) Emergent properties and structural patterns in sexually transmitted infection and HIV research. Sex Transm Infect 86: iii4-9.
20. Congreso de la Nación (2012) Identidad de género. Ley 26.743.
21. Dos Ramos Farías MS, Garcia MN, Reynaga E, Romero M, Vaulet ML, et al. (2011) First report on sexually transmitted infections among trans (male to female transvestites, transsexuals, or transgender) and male sex workers in Argentina: high HIV, HPV, HBV, and syphilis prevalence. Int J Infect Dis 15: e635-640.